A recent pilot study, led by Kieran Hyslop et al. and published in Scientific Reports, explored the potential role of circulating cell-free mitochondrial DNA (cf-mtDNA) as a predictor of postoperative complications in patients undergoing surgical aortic valve replacement (AVR). Although AVR remains the standard and highly effective treatment for severe aortic valve disease, managing post-surgical…